Literature DB >> 22885273

Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2.

S K Joseph1, S Sambanthamoorthy, G Dakshinamoorthy, G Munirathinam, K Ramaswamy.   

Abstract

Biolistic vaccination using gene gun is developed as a safer tool for delivery of DNA vaccines, a technique that combines high vaccine efficiency with lower antigen dosage and lower cost per vaccine dose. In this study, we compared the protective responses in mice after delivering the Brugia malayi abundant larval transcript-2 (BmALT-2) DNA vaccine using the conventional intradermal approach or with the needleless gene gun delivery approach. BmALT-2 is a leading vaccine candidate against B. malayi, a lymphatic filarial parasite of human. After optimizing the DNA dose and gene gun parameters for delivery into mouse skin, groups of mice were biolistically vaccinated with 5 μg of BmALT-2pVAX. Groups of mice vaccinated intradermally with 5 μg or 100 μg of BmALT-2pVAX was used for comparison of vaccine efficacy. Results demonstrated that gene gun vaccination with 5 μg of BmALT-2pVAX conferred significant protection against challenge infection that was comparable to the degree of protection conferred by intradermal vaccination with 100 μg of BmALT-2pVAX. This observation was further supported by an in vitro antibody dependent cellular cytotoxicity (ADCC) assay. Analysis of the immune response showed that the gene gun vaccination predominantly induced an IgG1 antibody response and significantly high Th2 cytokine response (IL-4) from spleen cells compared to intradermal BmALT-2 DNA delivery that induced predominantly an IgG2a and Th1 cytokine response (IFN-γ, IL-12 and TNF-α). These findings show that host protective responses could be achieved with 20 fold decrease in DNA dose using a gene gun and could prove to be an efficient delivery method in BmALT-2 DNA vaccination against lymphatic filariasis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885273      PMCID: PMC3467021          DOI: 10.1016/j.vaccine.2012.07.084

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

1.  Immune responses to Brugia malayi paramyosin in rodents after DNA vaccination.

Authors:  B W Li; S Zhang; K C Curtis; G J Weil
Journal:  Vaccine       Date:  1999-08-20       Impact factor: 3.641

2.  The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination.

Authors:  Sabarinathan Ramachandran; Mishra Pankaj Kumar; Reddy Maryada Venkata Rami; Harinath Basker Chinnaiah; Thomas Nutman; Perumal Kaliraj; James McCarthy
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

3.  Membranes from both Th1 and Th2 T cell clones stimulate B cell proliferation and prepare B cells for lymphokine-induced differentiation to secrete Ig.

Authors:  P D Hodgkin; L C Yamashita; B Seymour; R L Coffman; M R Kehry
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

4.  DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

Authors:  J S Boyle; A Silva; J L Brady; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory.

Authors:  D M Klinman; J M Sechler; J Conover; M Gu; A S Rosenberg
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

6.  Brugia malayi: serum dependent cell-mediated reactions to microfilariae.

Authors:  R Chandrashekar; U R Rao; P B Parab; D Subrahmanyam
Journal:  Southeast Asian J Trop Med Public Health       Date:  1985-03       Impact factor: 0.267

7.  Immunity to larval Brugia malayi in BALB/c mice: protective immunity and inhibition of larval development.

Authors:  D Abraham; R B Grieve; J M Holy; B M Christensen
Journal:  Am J Trop Med Hyg       Date:  1989-06       Impact factor: 2.345

8.  Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses.

Authors:  E Raz; D A Carson; S E Parker; T B Parr; A M Abai; G Aichinger; S H Gromkowski; M Singh; D Lew; M A Yankauckas
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Transfection by particle bombardment: delivery of plasmid DNA into mammalian cells using gene gun.

Authors:  Masaki Uchida; Xiong Wei Li; Peter Mertens; H Oya Alpar
Journal:  Biochim Biophys Acta       Date:  2009-05-27

10.  Antibody responses to Brugia malayi antigens induced by DNA vaccination.

Authors:  Ben-Wen Li; Amy Rush; Shaorong R Zhang; Kurt C Curtis; Gary J Weil
Journal:  Filaria J       Date:  2004-01-22
View more
  5 in total

1.  Immunogenicity of Brugia malayi Abundant Larval Transcript-2, a potential filarial vaccine candidate expressed in tobacco.

Authors:  Mathangi Ganapathy; Adhiseshan Perumal; Chakravarthi Mohan; Harunipriya Palaniswamy; Kaliraj Perumal
Journal:  Plant Cell Rep       Date:  2013-11-07       Impact factor: 4.570

2.  Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential.

Authors:  Vikas Kushwaha; Prachi Tewari; Payal Mandal; Anurag Tripathi; P Kalpana Murthy
Journal:  Parasitol Res       Date:  2019-05-04       Impact factor: 2.289

3.  Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.

Authors:  S K Joseph; K Ramaswamy
Journal:  Vaccine       Date:  2013-06-02       Impact factor: 3.641

Review 4.  Examining the role of macrolides and host immunity in combatting filarial parasites.

Authors:  Doug S Carithers
Journal:  Parasit Vectors       Date:  2017-04-14       Impact factor: 3.876

5.  Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection.

Authors:  Sridhar Arumugam; Junfei Wei; Zhuyun Liu; David Abraham; Aaron Bell; Maria Elena Bottazzi; Peter J Hotez; Bin Zhan; Sara Lustigman; Thomas R Klei
Journal:  PLoS Negl Trop Dis       Date:  2016-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.